Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2013 it was 76.7%, against -31.6% the year before. The highest annual figure on record is 76.7% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 76.7% | +108.4 |
| FY2012 | Dec 31, 2012 | -31.6% | −8.9 |
| FY2011 | Dec 31, 2011 | -22.8% | +48.8 |
| FY2010 | Dec 31, 2010 | -71.5% | −54.7 |
| FY2009 | Dec 31, 2009 | -16.9% | – |
See a number that looks wrong?